Cannabis and Pancytopenia - a phase IV clinical study of FDA data

Summary:

Pancytopenia is reported as a side effect among people who take Cannabis (marijuana), especially for people who are male, 30-39 old, have been taking the drug for 6 - 12 months also take Solu-Medrol, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Pancytopenia when taking Cannabis. It is created by eHealthMe based on reports of 12,664 people who have side effects when taking Cannabis from the FDA, and is updated regularly.

What is Cannabis?

Cannabis has active ingredients of marijuana. It is often used in stress and anxiety. eHealthMe is studying from 13,371 Cannabis users. Check the latest studies of Cannabis.

What is Pancytopenia?

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets) is found to be associated with 1,793 drugs and 2,431 conditions by eHealthMe. Check the latest studies of Pancytopenia.

On Jul, 11, 2026

12,664 people reported to have side effects when taking Cannabis.
Among them, 11 people (0.09%) have Pancytopenia.

Among these 11 people:

How long have people been on Cannabis when they have Pancytopenia? *

What is the gender of people who have Pancytopenia when taking Cannabis? *

female: 10 %
male: 90 %

What is the age of people who have Pancytopenia when taking Cannabis? *

What are other drugs people take besides Cannabis? *

What are other side effects people have besides Pancytopenia? *

Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 63.64%
Migraine With Aura (headache with vision weakness): 7 people, 63.64%
Encephalitis Viral (inflammation of the brain due to viral infection): 7 people, 63.64%
Cytomegalovirus Infection: 7 people, 63.64%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 7 people, 63.64%
Dermatitis Allergic (inflammation of the skin due allergic reaction): 7 people, 63.64%
Constipation: 6 people, 54.55%
Oral Candidiasis (fungal infection of mouth): 4 people, 36.36%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 1 person, 9.09%
Gait Disturbance: 1 person, 9.09%

What are the existing conditions these people have? *

Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 7 people, 63.64%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 63.64%
Upper Respiratory Tract Infection: 1 person, 9.09%
Suicide Attempt: 1 person, 9.09%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 9.09%
Parkinson's Disease: 1 person, 9.09%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 9.09%
Muscle Spasms (muscle contraction): 1 person, 9.09%
Multiple Myeloma (cancer of the plasma cells): 1 person, 9.09%
Folate Deficiency (lack of folic acid): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cannabis and have Pancytopenia?

- Check whether Pancytopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cannabis:

Cannabis (13,371 reports)

Pancytopenia treatments and more:

Pancytopenia (69,290 reports)

Browse all side effects of Cannabis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pancytopenia:

Pancytopenia (1,793 drugs)

Browse all the conditions that are associated with Pancytopenia:

Pancytopenia (2,431 conditions)

Related publications that referenced our studies

Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on marijuana (the active ingredients of Cannabis) and Cannabis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.